Skip to main content
Figure 3 | Trials

Figure 3

From: A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

Figure 3

COSIRA study flow. AE, adverse event; CCS, Canadian Cardiovascular Society; CMR, cardiac magnetic resonance imaging; CT, computerized tomography; ECG, electrocardiogram; ECHO, echocardiogram; ETT, exercise tolerance test; MIBI, sestamibi; RHC, right heart catheterization; SAE, serious adverse event; SAQ, Seattle Angina Questionnaire; SPECT; single-photon emission computed tomography.

Back to article page

Trials

ISSN: 1745-6215